All posts by Genetic Signatures
Genetic Signatures are proud to exhibit at the Australian Society for Microbiology Annual Scientific Meeting (ASM) 2017 in Hobart, Tasmania on 2-5 July 2017.
Genetic Signatures has also been selected to present 4 oral papers at ASM 2017 Tasmania, in the following sessions:
- Monday 3rd July, 2017 10:30-12:00pm EST
Session: Laboratory Processes and Automation
“Clinical evaluation of the 3base™ EasyScreenTM Enteric Viral Detection Kit EV002”
- Monday 3rd July, 2017 15.30-17:00pm EST
Session: Virus-host interactions
“A novel 3base™ assay for the rapid detection of flavivirus/alphavirus in clinical samples
- Tuesday 4th July, 2017 10:30-12:00pm EST
Session: New Clinical Microbiology Diagnostics
“A 3base™ Real-Time Multiplex-PCR method for the detection of Extended-Spectrum β-Lactamases (ESBL) and Carbapenemase-Producing Organisms (CPO)”
- Tuesday 4rd July, 2017 15:30-17:00pm EST
Session: STIs and Diagnostics
“Rapid, Sensitive and Automated Detection of 12 Bacterial and Viral Causes of Sexually Transmitted Infections using the 3base™ EasyScreenTM Sexually Transmitted/Genital Detection Kit”
You are invited to visit Genetic Signatures at Booth no. 17 and to attend the oral presentations at ASM 2017 Tasmania.
About ASM 2017 Tasmania: The Australian Society for Microbiology Annual Scientific Meeting (ASM) was formed in 1959 as a learned society devoted to furthering the science of microbiology. The ASM became an incorporated professional society in 1976.
With the theme of Planetary Health, the scientific program emphasizes the interdependent nature of life on Earth and how this relates to the health of mankind. An exciting new discipline, Planetary Health encompasses broad microbial systems that impact disease and epidemiology, climate change, food production and many broad natural systems. The annual meeting represents an opportunity to showcase products and technology to over 500 delegates from both diagnostic and research backgrounds.
Genetic Signatures Announces Regulatory Approval for Complete Enteric Product Suite in Australia and Europe and secures 3baseTM Patent in USA
Genetic Signatures are pleased to be exhibiting at ASM Microbe 2017 in New Orleans, Louisiana, United States, 1-5 June 2017.
The ASM Microbe conference showcases the best microbial sciences in the world and provides a one-of-a-kind forum to explore the complete spectrum of microbiology from basic science to translation and application.
You are invited to visit Genetic Signatures at Booth no. 1304 at ASM Microbe 2017.
About ASM Microbe: ASM Microbe 2017 is the largest gathering of microbiologists in the world and the only meeting in the field that explores the full scope of microbiology – from basic science to translational and clinical application. By integrating ASM’s two most popular events, General Meeting and ICAAC, ASM Microbe 2017 provides unparalleled learning and networking opportunities that you cannot find anywhere else.
Genetic Signatures will be exhibiting at the 33rd ASM Clinical Virology Symposium (CVS) Savannah, Georgia, United States, 07-10 May 2017.
Presented by ASM- The Clinical Virology Symposium is a 3-day event highlighting the relationship between rapid viral diagnosis, clinical course of viral infections and preventive and therapeutic modalities for viral infections being the theme of this premier meeting. Discussion of timely topics by renowned scientists assures that this symposium will be informative and engaging, while newly acquired information about clinically relevant viral infections will be useful to practicing physicians who can apply this knowledge in a clinical setting.
Visit Genetic Signatures at Booth #435 at CVS 2017 for more information.
About ASM Clinical Virology Symposium: ASM Clinical Virology Symposium is led by biomedical scientists engaged in research as well as primary care physicians and laboratory professions involved with patient care. This international symposium will provide an unmatched forum for the meaningful exchange of ideas dealing with viral infections.
GenomeWeb, the largest online newsroom focused on advanced molecular research tools, has featured Genetic Signatures and 3base™ technology, in an article about the company’s continued global market rollout of their existing and new suite of products. The new 3base™ multiplex PCR tests include an assay for detecting sexually transmitted infections and another that tests for all flaviviruses and alphaviruses. These assays complement Genetic Signatures’ tests already available which include assays for enteric and respiratory infections. The GenomeWeb article highlighted Genetic Signatures’ recent clinical trial of their new EasyScreenTM Flavivirus/Alphavirus Detection kit, which was presented at the infectious diseases conference, ECCMID, in April 2017 (Vienna, Austria). The article also discussed the ongoing global expansion strategy including the progress of regulatory approval in Australia and a CE-IVD marking of a number of products in the coming months.
Genetic Signatures’ Chief Scientific Officer, Dr Doug Millar, will be presenting at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) on the 23rd April 2017 in Vienna, Austria.
Dr Millar will present results on the development of a 3base™ Flavivirus and Alphavirus Detection kit. The test allows for the detection of 15 of the most common flavivirus and alphavirus infections in the world, including dengue, West Nile virus, Zika, yellow fever virus, and chikungunya.
“Our novel 3baseTM technology allows for screening of diverse families of viruses in a single assay. The simultaneous screening of these flavivirus and alphavirus groups will provide faster results thus allowing for more effective treatment and reduce the risk of transmission to healthy individuals” said Dr Millar.
We invite you to hear Dr Millar’s presentation at ECCMID 2017
Session: New approaches in molecular diagnostic virology
Location Hall C: April 23rd, 2017 at 14.30-15.30 (CEST).
Dr. Millar and Genetic Signatures’ CEO, Dr. Melki, will both be present for the duration of the conference at booth #137. They will be available to discuss Genetic Signatures’ suite of products for the detection of infectious diseases, including flavivirus and alphavirus as well as reagents for diagnosing bacterial, viral and protozoan causes of gastroenteritis, respiratory infections, and sexually transmitted infections.
Visit Genetic Signatures at Booth #137 at ECCMID 2017 for more information.
About EasyScreen™ Flavivirus/Alphavirus Detection Kit: The EasyScreen™ Flavivirus/Alphavirus Detection Kit includes targets for Pan-flavivirus, Pan-alphavirus, Pan-dengue 1-4 (DENV), Zika Virus (ZIKV), West Nile virus (WNV), yellow fever virus (YFV), St Louis encephalitis virus (SLEV), tick-borne encephalitis virus (TBEV), and Japanese encephalitis virus (JEV) and chikungunya (CHIKV). The EasyScreen™ Flavivirus/Alphavirus Detection Kit is currently for Research Use Only (RUO).
About ECCMID: The 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) is one of the largest European Infectious diseases meetings. The congress provides a forum for the world’s leading experts who come together to discuss the latest developments in diseases, infection control, and clinical microbiology.